LLVK (TFA)
LLVK TFA is a selective IκB phosphorylation inhibitor. LLVK TFA reduces LPS-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) . LLVK TFA is promising for research of inflammatory bowel disease and rheumatoid arthritis[1].
Product Specifications
UNSPSC
12352209
Target
IKK; NF-κB
Related Pathways
NF-κB
Field of Research
Inflammation/Immunology
Purity
99.50
Smiles
O=C(O)C(F)(F)F.O=C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(O)=O)=O)=O)[C@H](CC(C)C)N
Molecular Formula
C25H46F3N5O7
Molecular Weight
585.66
References & Citations
[1]Liu W, et al. Alternation in sequence features and their influence on the anti-inflammatory activity of soy peptides during digestion and absorption in different enzymatic hydrolysis conditions. Food Chem. 2025 Apr 15;471:142824.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6449563-01 0.1 mL
SREBF2 (Sterol Regulatory Element-binding Transcription Factor 2, Sterol Regulatory Element-binding Protein 2, SREBP2, BHLHd2, SREBP-2) (Biotin)
Sign In for Pricing
View Details MBS6449563-02 5x 0.1 mL
SREBF2 (Sterol Regulatory Element-binding Transcription Factor 2, Sterol Regulatory Element-binding Protein 2, SREBP2, BHLHd2, SREBP-2) (Biotin)
Sign In for Pricing
View Details 
E3373-05C-ML405 100 µL
EphB4 (Ephrin type-B receptor 4, HTK, MYK1, Tyro11, TYRO11) (MaxLight 405) discontinued
Sign In for Pricing
View Details